Company Novogined Srl with Fiscal Code 35312757
recorded a turnover of 2024 of
59.900,
with a net profit of
47.774
and having an average number of employees of
- .
The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Novogined Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
5.709
52.557
63.253
42.578
47.492
46.757
50.248
49.579
57.650
59.900
Total Income - EUR
5.709
52.563
63.264
42.578
47.492
46.757
50.248
49.579
57.650
59.900
Total Expenses - EUR
2
3.468
4.186
4.239
4.791
4.697
4.793
5.040
9.602
10.365
Gross Profit/Loss - EUR
5.707
49.095
59.078
38.340
42.701
42.060
45.455
44.539
48.049
49.535
Net Profit/Loss - EUR
5.536
47.518
57.181
37.063
41.276
40.760
44.050
43.207
47.484
47.774
Employees
0
0
0
1
1
1
1
1
1
0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 4.5%, from 57.650 euro in the year 2023, to 59.900 euro in 2024.
The Net Profit increased by 555 euro, from 47.484 euro in 2023, to 47.774 in the last year.
Check the financial reports for the company - Novogined Srl
Financial Rating - NOVOGINED SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Novogined Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Novogined Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Novogined Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
71.493 euro in 2024 which includes Inventories of
0 euro, Receivables of
51.732 euro and cash availability of
19.761 euro.
The company's Equity was valued at
47.822 euro, while total Liabilities amounted to
23.671 euro.
Equity increased by 555 euro, from 47.532 euro in 2023, to 47.822 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Novogined Srl